Ascendis Pharma (ASND) Earnings
|
Expand Research on ASND
| Next EPS Date | 11/11/26 | EPS Growth Rate | +193.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -96.6% | Revenue Growth Rate | +69.5% |
| Average % Move 1-Wk after EPS | +3.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | EUR0.93 | N/A | N/A | EUR362.08M | N/A | N/A | N/A | ||
| 8/13/26 | Q226 | EUR2.83 | EUR1.51 | +EUR1.32 | EUR339.28M | EUR326.45M | N/A |  | | Details | |
| 8/6/26 |
Q226 | N/A | EUR1.51 | N/A | N/A | EUR327.09M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | EUR0.27 | EUR0.18 | +EUR0.09 | EUR246.6M | EUR269.95M | N/A | | | Details | |
| 5/4/26 |
Q126 | N/A | EUR0.18 | N/A | N/A | EUR269.95M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | EUR0.18 | N/A | N/A | EUR269.95M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | EUR0.18 | N/A | N/A | EUR269.95M | N/A | N/A | N/A | ||
| 2/11/26 | Q425 | -EUR0.55 | -EUR0.15 | -EUR0.40 | EUR240M | EUR245.68M | N/A | | | Details |
